The FDA had approved Otulfi in September 2024 to treat Crohn’s disease, ulcerative colitis, psoriasis and active psoriatic arthritis. Information on pricing is not yet available.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback